Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
Shqipdona LahuKristin AdlerKatharina MayerRalph Hein-RothweilerIsabell BernlochnerGjin NdrepepaStefanie SchüpkeStefan HoldenriederDario BongiovanniKarl-Ludwig LaugwitzHeribert SchunkertMeinrad GawazSteffen MassbergAdnan KastratiGötz MünchPublished in: Thrombosis and haemostasis (2023)
In patients with CCS undergoing PCI, plasma levels of sGPVI did not correlate with ADP- or collagen-induced platelet aggregation. Patients with higher baseline levels of sGPVI may carry an increased risk of bleeding at 30 days after PCI but no excess risk of ischemic events.
Keyphrases
- percutaneous coronary intervention
- patients undergoing
- atrial fibrillation
- st segment elevation myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- coronary artery disease
- coronary artery bypass grafting
- ischemia reperfusion injury
- high glucose
- diabetic rats
- cerebral ischemia
- coronary artery bypass
- drug induced
- wound healing
- left ventricular
- brain injury
- blood brain barrier
- subarachnoid hemorrhage